Latest International Markets News

Lark Distilling Co. Ltd grew net sales by 15% in FY26, driven by whisky and international expansion, but posted a $40 million loss after goodwill and inventory impairments.

Temas Resources posted a CAD 2.63 million loss for H1 2026, driven by ramped-up exploration and RCL technology development, while securing $1.5 million in fresh funding and signing initial RCL licensing contracts.

Sigma Healthcare will release its FY26 full year results on 27 August, unveiling a new segment reporting structure dividing Australia and International operations. The update aims to clarify performance amid ongoing international growth and merger integration.

Chrysos Corporation posted a 33% revenue increase and 68% EBITDA growth in FY26, driven by expanding its PhotonAssay™ technology fleet to 46 units worldwide and signing 24 new lease agreements.

Amotiv Limited (ASX: AOV) delivered a solid FY26 with a $75.1 million net profit, reversing last year’s loss, underpinned by 2.7% revenue growth and strong cash conversion. The company declared a fully franked 23 cent final dividend and advanced its Amotiv Unified transformation and climate initiatives.

Life360 has surged past 100 million monthly active users, posting record revenue and subscriber growth in Q2 2026. Its AI-driven platform and expanding advertising business underpin strong profitability and a confident outlook.

Philips has officially declared compatibility for Imricor’s interventional MR devices with its magnetic resonance systems, enabling commercial clinical use and collaboration at a leading cardiology congress.

Australian Silica Quartz Group (ASQ) has secured mining approval and completed the acquisition of Australian Kaolin, positioning its White Swan Kaolin Project for production with a 47.3Mt inferred resource and a 250,000tpa direct shipping ore operation.

OMG Group smashed its July sales record with net sales soaring to approximately $738,000, a 120% jump on last year, reversing typical seasonal declines and boosted by a refreshed Blue Dinosaur brand.

Clarity Pharmaceuticals bolsters its commercial readiness with a $178.3 million cash reserve and a key US manufacturing agreement, while clinical trials for its prostate cancer imaging and therapeutic agents progress with promising data.

Vanadium Resources pivots to a co-production V-Iron Plant at Steelpoortdrift, securing a non-binding offtake with US Vanadium and appointing Rand Merchant Bank to drive project financing.

Swift TV Limited has completed its transition from development to commercial rollout, securing Google certification and Netflix approval while expanding contracts across aged care, hospitality, and workforce accommodation.